Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Test Cross01:39

Test Cross

43.8K
Alleles are different forms of the same gene. Humans and other diploid organisms inherit two alleles of every gene, one from each parent.
43.8K
Genetic Screens02:46

Genetic Screens

5.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K
Complementation Tests00:49

Complementation Tests

6.1K
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bispecific antibodies in solid tumors: An Italian Association of Medical Oncology (AIOM) multidisciplinary perspective on immunology and vaccination.

Critical reviews in oncology/hematology·2026
Same author

Implementation of infection prevention and control components in Italian hospitals based on a nationwide survey on behalf of INSIEME project.

Scientific reports·2025
Same author

Pharmacological and Adjunctive Management of Non-Hospitalized COVID-19 Patients During the Omicron Era: A Systematic Review and Meta-Analysis.

Viruses·2025
Same author

Bacteriophage-enhanced doxycycline activity against Escherichia coli in chronic bacterial prostatitis.

International journal of antimicrobial agents·2025
Same author

Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target Trials.

Journal of medical virology·2025
Same author

Ceftolozane/tazobactam use and emergence of resistance: a 4-year analysis of antimicrobial susceptibility in <i>Pseudomonas aeruginosa</i> isolates in a tertiary hospital.

Frontiers in microbiology·2025
Same journal

Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.

Scandinavian journal of infectious diseases. Supplementum·2009
Same journal

Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.

Scandinavian journal of infectious diseases. Supplementum·2009
Same journal

Supreme Court decision on genotypic tests for antiretroviral drugs resistance: Joint Criminal Divisions.

Scandinavian journal of infectious diseases. Supplementum·2004
Same journal

Brief summary of the legal proceeding.

Scandinavian journal of infectious diseases. Supplementum·2004
Same journal

Too early or too late: a never-ending dilemma with new technologies.

Scandinavian journal of infectious diseases. Supplementum·2004
Same journal

Genotypic resistance tests for the management of postexposure prophylaxis.

Scandinavian journal of infectious diseases. Supplementum·2004
See all related articles

Related Experiment Video

Updated: Jan 15, 2026

High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay
06:41

High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay

Published on: March 10, 2020

10.1K

Phenotypic resistance testing.

Massimo Andreoni1

  • 1Department of Public Health, University 'Tor Vergata', Rome, Italy.

Scandinavian Journal of Infectious Diseases. Supplementum
|March 6, 2004
PubMed
Summary
This summary is machine-generated.

Automated human immunodeficiency virus (HIV) testing offers new ways to manage antiretroviral therapy. Phenotypic testing may provide a more quantitative assessment of drug resistance, especially in cases of discordant results.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.1K
Protocols for Robust Herbicide Resistance Testing in Different Weed Species
10:52

Protocols for Robust Herbicide Resistance Testing in Different Weed Species

Published on: July 2, 2015

15.1K

Related Experiment Videos

Last Updated: Jan 15, 2026

High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay
06:41

High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay

Published on: March 10, 2020

10.1K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.1K
Protocols for Robust Herbicide Resistance Testing in Different Weed Species
10:52

Protocols for Robust Herbicide Resistance Testing in Different Weed Species

Published on: July 2, 2015

15.1K

Area of Science:

  • Virology
  • Clinical Pharmacology
  • Molecular Diagnostics

Background:

  • Automated genotypic and phenotypic assays for human immunodeficiency virus (HIV) are now available for managing antiretroviral therapy.
  • Phenotypic assays determine drug susceptibility by measuring the concentration of drug inhibiting viral replication.
  • Interpreting phenotypic assay results is complex, suggesting a need to consider relative drug activity over simple active/inactive classifications.

Purpose of the Study:

  • To evaluate the clinical utility of genotypic and phenotypic assays in managing antiretroviral therapy.
  • To address the complexity in interpreting phenotypic assay results.
  • To investigate the clinical significance of discordant results between phenotypic and genotypic testing.

Main Methods:

  • Utilized automated assay technology for genotypic and phenotypic characterization of HIV in plasma samples.
  • Performed phenotypic drug susceptibility testing using viral replication in tissue culture.
  • Compared results from phenotypic and genotypic testing in patients receiving antiretroviral therapy.

Main Results:

  • A high incidence of discordance between phenotypic and genotypic results was observed in treated patients.
  • The choice of antiretroviral drug regimen may vary depending on whether phenotypic or genotypic data is used.
  • Phenotypic testing may offer a more quantitative assessment of viral resistance, particularly in discordant cases.

Conclusions:

  • Interpreting phenotypic HIV drug resistance requires considering relative drug activity.
  • Discordance between phenotypic and genotypic testing has significant clinical implications for treatment selection.
  • Further clinical validation is required to determine the optimal approach for utilizing genotypic and phenotypic assay results in patient management.